An open-label randomized controlled trial comparing the efficacy and safety of pemetrexed-carboplatin versus (weekly) paclitaxel-carboplatin as first-line chemotherapy in advanced non-squamous non-small cell lung cancer - Yadav, A; Malik, P S; Khurana, S (Oncology, 2021)